Biotech Firm's Shares Plummet Amid Planned Pivot to Dogecoin Mining
Dogecoin mining is quite the shift for biotech firm Coeptis Therapeutics, and shareholders don't appear thrilled with the proposed move.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This mining story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Tether’s mining development kit gets backing from 15 mining firms
Tether's MDK initiative could revolutionize Bitcoin mining by fostering interoperability and automation, potentially reshaping ind...
CoinShares BTF Liquidation Sets Cash Payout And Earlier Options Expiry
TL;DR: CoinShares’ Bitcoin and Ether ETF has reached cash settlement. An OCC notice confirms the payout and brings later-dated BTF...
Bitwise Dogecoin ETF Reaches Scheduled Liquidation As Holders Face Cash Redemption
TL;DR: Bitwise’s BWOW Dogecoin ETF reached its announced October 22 liquidation distribution date, with remaining shareholders due...
Bitcoin Hashrate Reclaims One Zettahash As Mining Competition Rebounds
TL;DR: BlocksBridge reported Bitcoin’s seven-day hashrate above one zettahash in the week to October 22. Mining competition has re...
Blumenthal Asks Tether to Detail Every Payment to Nxum, Bo Hines’ Consulting Firm
Sen. Richard Blumenthal (D-Conn.), the ranking member of the Senate Permanent Subcommittee on Investigations, demanded records on...
Bitcoin Is Busier Than Ever, but Bitcoin Mining Isn’t Getting Paid More
Bitcoin is processing more transactions than ever before on an annual basis, but the growing activity is doing little to improve o...